+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of functional digestive disorders with a drug composed of a neuroleptic and an anticholinergic agent



Treatment of functional digestive disorders with a drug composed of a neuroleptic and an anticholinergic agent



La Presse Medicale 79(13): 585-586




(PDF emailed within 1 workday: $29.90)

Accession: 044855409

Download citation: RISBibTeXText

PMID: 5553539


Related references

The treatment of digestive functional disorders with a drug composed of a neuroleptic and an anti cholinergic. Presse Medicale:, 1971

Treatment of some functional disorders of the digestive system: clinical experimentation with comparison of a medazepam-metoclopramide combination with medazepam-anticholinergic agent combination. La Clinica Terapeutica 72(2): 141-157, 1975

Use in digestive pathology of the association of: a major neuroleptic and an anticholinergic. Journal de Medecine de Lyon 50(165): 877-8 Passim, 1969

The choice of anticholinergic drugs in the treatment of functional digestive diseases. American Journal of Digestive Diseases 4(4): 260-275, 1959

Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study. Drugs & Aging 30(11): 927-934, 2014

First results of the treatment of 60 cases of mental disorders with a new neuroleptic agent, haloperidol (R 1625). Rivista Sperimentale di Freniatria E Medicina Legale Delle Alienazioni Mentali 84: 248-260, 1960

The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. Journal of Clinical Pharmacology 46(12): 1481-1486, 2006

Use of a new anticholinergic agent in digestive pathology and especially in gastroduodenal ulcers. Marseille Medical 99: 609-615, 1962

Movement disorders with neuroleptic drug treatment. Psychiatric Clinics of North America 7(3): 453-471, 1984

Treatment of anticholinergic drug induced cognitive disorders Clinical effects and prognosis. Journal of Toxicology Clinical Toxicology 41(5): 668, August, 2003

Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug. Canadian Medical Association Journal 126(7): 821-2, 827, 1982

Neuroleptic and anticholinergic drug use in Chinese patients with schizophrenia resident in a state psychiatric hospital in Singapore. Australian and New Zealand Journal of Psychiatry 34(6): 988-991, 2000

Treatment of the functional disorders and motor disorders of the upper digestive tract with a new pharmacological preparation acting on the brain stem centers. Hospital 70(4): 863-882, 1966

Therapeutic action of the new synthetic anticholinergic agent, benzylonium bromide, in diseases of the digestive tract. Medicina Clinica 40: 181-185, 1963

An Anticholinergic Drug (Md-5579) In Digestive Radiology. Annales de Radiologie 7: 731-738, 1964